Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance
Revenue—+14.5% YoY
EPS$0.53
Outlookmaintainedguidance
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Forensic equity research on US stocks. No spam, unsubscribe anytime.